Creation of a drug fund for post-clinical trial access to antiretrovirals

Lancet. 2004 Jul;364(9428):101-2. doi: 10.1016/S0140-6736(04)16596-3.
No abstract available

MeSH terms

  • Anti-Retroviral Agents / economics
  • Anti-Retroviral Agents / therapeutic use*
  • Clinical Trials as Topic / ethics*
  • Financial Management
  • HIV Infections / drug therapy*
  • HIV Infections / economics
  • Health Services Accessibility
  • Helsinki Declaration
  • Humans

Substances

  • Anti-Retroviral Agents